S
Sweetch
The first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions
About Sweetch
Sweetch is a digital therapeutics company that has developed a platform to manage chronic diseases through hyper-personalized interventions. The platform utilizes a combination of artificial intelligence, behavioral science, and emotional intelligence to engage patients in their self-care.
Read full description
The core of the service is a mobile application that functions as a digital health coach. It collects and analyzes millions of data points from a user's smartphone and connected devices. This data is then translated into condition-specific recommendations and reminders designed to help patients manage their health goals and adhere to treatment programs. The company targets individuals living with chronic conditions, including cancer, and aims to improve health outcomes by providing continuous, adaptive support.
The business model appears to be B2B, partnering with healthcare providers and organizations to offer the platform to their patients. By providing a tool for large-scale prediction, prevention, and management of chronic diseases, Sweetch offers a solution to improve patient outcomes and potentially reduce healthcare costs.
At a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Tel Aviv-Yafo, Israel
- Employees
- 42
- Open positions
- None listed
- Dealroom signal
- 63.2/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Personal Health, Diabetes, Risk Management, Analytics, Data Analytics
- Technology
- Artificial Intelligence, Big Data, Machine Learning, Computer Vision, Connected Device
- Business model
- SaaS
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2025 | $9M | $36M | Undisclosed | — |
| SERIES A✓Equity / VC | Jul 2021 | $20M | $80M | Tal Capital · Entrée Capital · OurCrowd · Noaber | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Sweetch is 1.2K monthly website visits, up 135.3% over the last three months. Sweetch's team declined 23.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
SeedIL
Series A11 investors entered at this stage
OurCrowd
Pontifax Funds
Philips
LionBird
Entrée Capital- TCTal Capital
Noaber
Philips Ventures
FinTLV
Kortex Ventures
Qure Ventures
Other known investors6 additional known investors
Cynthia Phitoussi
G4A- GOGilbert Ohana
Philips Healthcare
Tal Ventures
Tenmile
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sweetch on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sweetch’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.